Akers Biosciences Inc. | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.42 |
Market Cap |
GBP18.31 M |
Shares Outstanding |
94.11 M |
Public Float |
81.73 M |
Akers Biosciences Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.82 |
Market Cap |
$5.42 M |
Shares Outstanding |
12.47 M |
Public Float |
12.12 M |
Address |
201 Grove Road West Deptford New Jersey 08086 United States |
Employees | - |
Website | http://www.akersbio.com |
Updated | 07/08/2019 |
Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. |